Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial

Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial
复制标题

DOI:
10.1093/humrep/dei348
复制
发表时间:
2006-02-01
期刊:
影响因子:
6.1
通讯作者:
Devroey, P
Devroey, P
中科院分区:
医学1区
文献类型:
--
作者:
Kolibianakis, EM;Papanikolaou, EG;Devroey, P

文献摘要

被引文献

相似文献

背景技术背景:这项随机对照试验的目的是评估口服避孕药(OCP)预处理对接受GnRH拮抗剂治疗的IVF患者继续妊娠概率的影响。方法:425例患者在月经周期第2天(非OCP组:n = 211)或停用OCP后5天(OCP组:n = 214)开始使用固定剂量的200 IU重组FSH(rFSH)。促性腺激素释放激素拮抗剂在刺激的第6天开始,用10,000 IU的HCG触发最终的卵母细胞成熟。研究结果:非OCP组和OCP组每个开始周期的持续妊娠率分别为27.5%和22.9%[差异的95%置信区间(CI):-3.7至+12.8]。与非OCP组(21.6%)相比,OCP组(36.4%)的妊娠丢失率显着增加(差异的95%CI:-28.4至-2.3)。结论:与接受GnRH拮抗剂和重组FSH治疗的患者在周期第2天开始刺激相比,OCP预治疗似乎与每个开始周期的持续妊娠率无显著差异相关,并导致显着较高的早期妊娠丢失。
BACKGROUND: The objective of this randomized controlled trial was to assess the effect of oral contraceptive pill (OCP) pretreatment on the probability of ongoing pregnancy in patients treated with a GnRH antagonist for IVF. METHODS: A fixed dose of 200 IU recombinant FSH (rFSH) was started in 425 patients either on day 2 of the menstrual cycle (non-OCP group: n = 211) or 5 days after discontinuing the OCP (OCP group: n = 214). GnRH-antagonist was initiated on day 6 of stimulation, and triggering of final oocyte maturation was performed with 10,000 IU of HCG. RESULTS: Ongoing pregnancy rates per started cycle in the non-OCP and OCP group were 27.5% and 22.9%, respectively [95% confidence interval (CI) of the difference: -3.7 to +12.8]. Pregnancy loss was significantly increased in the OCP (36.4%) compared with the non-OCP group (21.6%) (95% CI of the difference: -28.4 to -2.3). CONCLUSION: Pretreatment with OCP, as compared with initiation of stimulation on day 2 of the cycle in patients treated with GnRH antagonist and recombinant FSH, appears to be associated with a not significant difference in ongoing pregnancy rates per started cycle and results in a significantly higher early pregnancy loss.